Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Non Operating Income (2016 - 2025)

Dare Bioscience (DARE) has disclosed Non Operating Income for 11 consecutive years, with $109382.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income rose 617.12% year-over-year to $109382.0, compared with a TTM value of $5309.0 through Sep 2025, up 100.71%, and an annual FY2024 reading of -$981490.0, down 226.08% over the prior year.
  • Non Operating Income was $109382.0 for Q3 2025 at Dare Bioscience, up from -$188683.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $340148.0 in Q1 2023 and bottomed at -$732883.0 in Q1 2024.
  • Average Non Operating Income over 5 years is $18988.3, with a median of $1779.0 recorded in 2022.
  • The sharpest move saw Non Operating Income soared 59200.0% in 2022, then tumbled 315.46% in 2024.
  • Year by year, Non Operating Income stood at $834.0 in 2021, then soared by 34353.72% to $287344.0 in 2022, then crashed by 60.36% to $113898.0 in 2023, then crashed by 203.78% to -$118201.0 in 2024, then skyrocketed by 192.54% to $109382.0 in 2025.
  • Business Quant data shows Non Operating Income for DARE at $109382.0 in Q3 2025, -$188683.0 in Q2 2025, and $202811.0 in Q1 2025.